Skip to main content
. 2021 Nov 28;13(23):5989. doi: 10.3390/cancers13235989

Table 3.

Blood patients’ CTCs.

Percentage CTCs Positive after Cell Screen Filtration n (%)
Positive 43 (89.6%)
Negative 5 (10.4%)
CTC specificity after ddPCR
EpCAM + /CK + /CD45- 40 (93.0%)
EpCAM + /CK − /CD45- 3 (7.0%)
EpCAM − /CK + /CD45- 0 (0.0%)
Patients pathological grade and stage n (%)
Total 40 (100%)
Tis 3 (7.5%)
Ta LG 27 (67.5%)
Ta HG 4 (10.0%)
T1 LG 6 (15.0%)
T1 HG 0 (0.0%)